Abstract
SIRT6 is one of the seven members of the NAD-dependent family of sirtuins mammals. The pleotropic identity of SIRT6 is manifested into several catalytic activities such as deacetylation, deacylation and ribosylation, which allow the targeting of a variety of protein substrates, that influence the physiology of multiple cell types and tissues. SIRT6- dependent deacetylation of histone H3 at lysines 9 and 56 is required for the regulation of genes associated with glucose/ lipid metabolism as well as the maintenance of telomeric regions and the repair of DNA double strand breaks. Importantly, SIRT6 depletion alters the levels of acetylated histone H3 causing a deregulation of genes involved in glycolysis and the Myc-target network, which results in tumorigenesis. Hence, SIRT6 has been recently categorized as a tumor suppressor. The deacylation activity of SIRT6 has been attributed to the regulation of TNF-α secretion. However, the physiological relevance of this newly discovered catalytic activity of SIRT6 remains to be determined in vivo. SIRT6 also undergoes auto-ribosylation, which might contribute to a self-regulation of catalytic functions. SIRT6-mediated ribosylation also enhances PARP1-dependent DNA repair under oxidative stress and aging. Overall, SIRT6 is a critical enzyme required to maintain glucose/lipid homeostasis and genomic stability, thereby promoting resistance to oxidative stress and DNA damage, which are associated to age-related illness. Evocative of its ancestor, yeast Sir2, SIRT6 has the ability to increase lifespan in mice. SIRT6 deficiency is associated with various diseases including inflammation, cardiac hypertrophy, liver dysfunction, adipocyte/muscle disorders, and cancer. This review describes the most current information regarding the molecular and physiological relevance of SIRT6 in the context of epigenetics, metabolism and disease.
Keywords: Aging, cancer, deacetylase, epigenetics, glycolysis, metabolism, sirtuin, SIRT6.
Current Topics in Medicinal Chemistry
Title:The Histone Deacetylase SIRT6: At the Crossroads Between Epigenetics, Metabolism and Disease
Volume: 13 Issue: 23
Author(s): Jean-Pierre Etchegaray, Lei Zhong and Raul Mostoslavsky
Affiliation:
Keywords: Aging, cancer, deacetylase, epigenetics, glycolysis, metabolism, sirtuin, SIRT6.
Abstract: SIRT6 is one of the seven members of the NAD-dependent family of sirtuins mammals. The pleotropic identity of SIRT6 is manifested into several catalytic activities such as deacetylation, deacylation and ribosylation, which allow the targeting of a variety of protein substrates, that influence the physiology of multiple cell types and tissues. SIRT6- dependent deacetylation of histone H3 at lysines 9 and 56 is required for the regulation of genes associated with glucose/ lipid metabolism as well as the maintenance of telomeric regions and the repair of DNA double strand breaks. Importantly, SIRT6 depletion alters the levels of acetylated histone H3 causing a deregulation of genes involved in glycolysis and the Myc-target network, which results in tumorigenesis. Hence, SIRT6 has been recently categorized as a tumor suppressor. The deacylation activity of SIRT6 has been attributed to the regulation of TNF-α secretion. However, the physiological relevance of this newly discovered catalytic activity of SIRT6 remains to be determined in vivo. SIRT6 also undergoes auto-ribosylation, which might contribute to a self-regulation of catalytic functions. SIRT6-mediated ribosylation also enhances PARP1-dependent DNA repair under oxidative stress and aging. Overall, SIRT6 is a critical enzyme required to maintain glucose/lipid homeostasis and genomic stability, thereby promoting resistance to oxidative stress and DNA damage, which are associated to age-related illness. Evocative of its ancestor, yeast Sir2, SIRT6 has the ability to increase lifespan in mice. SIRT6 deficiency is associated with various diseases including inflammation, cardiac hypertrophy, liver dysfunction, adipocyte/muscle disorders, and cancer. This review describes the most current information regarding the molecular and physiological relevance of SIRT6 in the context of epigenetics, metabolism and disease.
Export Options
About this article
Cite this article as:
Etchegaray Jean-Pierre, Zhong Lei and Mostoslavsky Raul, The Histone Deacetylase SIRT6: At the Crossroads Between Epigenetics, Metabolism and Disease, Current Topics in Medicinal Chemistry 2013; 13 (23) . https://dx.doi.org/10.2174/15680266113136660213
DOI https://dx.doi.org/10.2174/15680266113136660213 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Chronic Kidney Disease
The scope of the special thematic issue includes but not limited to the mechanism of chronic kidney disease (CKD), the treatment of renal fibrosis and early diagnosis of CKD and so on. We also welcome manuscripts from other scientific research area with respect to internal medicine. Cell death has been ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Influence of the Bystander Effect on HSV-tk / GCV Gene Therapy. A Review.
Current Gene Therapy The Ubiquitin-Proteasome System as a Prospective Molecular Target for Cancer Treatment and Prevention
Current Protein & Peptide Science Novel Patents and Cancer Therapies for Transforming Growth Factor- Beta and Urokinase Type Plasminogen Activator: Potential Use of Their Interplay in Tumorigenesis
Recent Patents on Anti-Cancer Drug Discovery Evaluation of Vitamin C as a Personalized Adjuvant Medicine: Pharmacogenomic Studies
Current Pharmacogenomics and Personalized Medicine Roles of Medicinal Plants and Constituents in Gynecological Cancer Therapy: Current Literature and Future Directions
Current Topics in Medicinal Chemistry Correlation Between <i>BCL2</i> and <i>Mcl1</i> Single Nucleotide Polymorphisms and Chemotherapy Response in Jordanian Patients with Colorectal Cancer
Current Pharmaceutical Biotechnology In Vitro and In Vivo Evaluation of DMSO and Azone as Penetration Enhancers for Cutaneous Application of Celecoxib
Current Drug Delivery Clinical Trials in Chemoprevention of Head and Neck Cancers
Reviews on Recent Clinical Trials The Use of L-Glucose in Cancer Diagnosis: Results from In Vitro and In Vivo Studies
Current Medicinal Chemistry Mast Cells and Basophils: Trojan Horses of Conventional Lin- Stem/Progenitor Cell Isolates
Current Pharmaceutical Design Regulation of Adrenomedullin and its Family Peptide by RAMP System – Lessons from Genetically Engineered Mice
Current Protein & Peptide Science Molecular Imaging Kits for Hexosamine Biosynthetic Pathway in Oncology
Current Medicinal Chemistry MADD Expression in Lung Adenocarcinoma and its Impact on Proliferation and Apoptosis of Lung Adenocarcinoma Cells
Combinatorial Chemistry & High Throughput Screening The HVJ-Envelope as an Innovative Vector System for Cardiovascular Disease
Current Gene Therapy Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer
Recent Patents on Anti-Cancer Drug Discovery Targeting Aldose Reductase for the Treatment of Cancer
Current Cancer Drug Targets Bortezomib in the Treatment of Cancer
Recent Patents on Anti-Cancer Drug Discovery DNA Drug Design for Cancer Therapy
Current Pharmaceutical Design Redox Status in Periodontal and Systemic Inflammatory Conditions Including Associated Neoplasias: Antioxidants as Adjunctive Therapy?
Infectious Disorders - Drug Targets Repressing the Activity of Protein Kinase CK2 Releases Mitochondria-Mediated Apoptosis in Cancer Cells
Current Drug Targets